HSTC
HST Global, Inc.
Key Financials
Revenue
$0
NaN%
Operating Income
$-140907
↑ 0.1%
Net Income
$-146210
↓ 0.8%
Total Assets
$1526.00
↑ 703.2%
Total Liabilities
$593593.00
↑ 33.1%
Shareholders' Equity
$-592067.00
↓ 32.8%
Cash & Equivalents
$1526.00
↑ 703.2%
Operating Cash Flow
$-20906.00
↑ 0.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D | 11/10/2025 | View on SEC |
| 15-12G | 11/3/2025 | View on SEC |
| 10-K | 11/3/2025 | View on SEC |
| NT 10-K | 4/2/2025 | View on SEC |
| NT 10-K | 3/31/2025 | View on SEC |
| 8-K | 3/20/2025 | View on SEC |
| 10-Q | 11/22/2024 | View on SEC |
| NT 10-Q | 11/15/2024 | View on SEC |
| 8-K | 11/12/2024 | View on SEC |
| 8-K | 9/26/2024 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HSTC |
| Company Name | HST Global, Inc. |
| CIK | 797564 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 800-961-4750 |